0001562180-16-002912.txt : 20160808
0001562180-16-002912.hdr.sgml : 20160808
20160808160158
ACCESSION NUMBER: 0001562180-16-002912
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160804
FILED AS OF DATE: 20160808
DATE AS OF CHANGE: 20160808
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dallas Jayson Donald Alexander
CENTRAL INDEX KEY: 0001650322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 161814112
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-08-04
false
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001650322
Dallas Jayson Donald Alexander
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
false
true
false
false
See Remarks
Common Stock
2016-08-04
4
F
false
940.00
64.24
D
12460.00
D
Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due upon vesting of Restricted Stock Units granted to the Reporting Person under the 2014 Incentive Plan of the Issuer. The shares surrendered were valued based on the closing price of the common stock of the Issuer on the date of surrender.
Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
EVP and Chief Commercial Officer
/s/ Shalini Sharp by power of attorney for Jayson Dallas
2016-08-08